Press Releases

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes

TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accele

November 13, 2024

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..

November 7, 2024

Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.

October 16, 2024

Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination...

October 1, 2024

Note: You are reading this information because Critical Path Institute is a partner of both ERA4TB and Unite4TB.

September 30, 2024

C-Path announced the formation of a new task for under its RDCA-DAP, dedicated to...

September 19, 2024

C-Path is thrilled to announce its PKDOC has been awarded...

September 12, 2024

C-Path successfully concluded its inaugural Global Impact Conference (CGIC) on September 11, 2024.

September 9, 2024

FDA) encouraged scientists and drug developers to use the alpha-synuclein seed amplification assay (αSyn-SAA) biomarker...

September 5, 2024

Critical Path Institute (C-Path) today announced the addition of significant new data sets...